I-Mab Reports Third Quarter 2024 Results - Nasdaq
Sep 30, 2024 · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024 , the Company had cash and cash equivalents, and short-term investments of $184.4 million , …
OFF
I-Mab Reports Third Quarter 2024 Results - Nasdaq
2 weeks from now
Sep 30, 2024 · Third Quarter 2024 Financial Results Cash Position As of September 30, 2024 , the Company had cash and cash equivalents, and short-term investments of $184.4 million , …
nasdaq.com
OFF
I-Mab Reports Third Quarter 2024 Results - Morningstar
2 weeks from now
1 day ago · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …
morningstar.com
OFF
I-Mab Reports Third Quarter 2024 Results
2 weeks from now
1 day ago · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …
i-mabbiopharma.com
OFF
I-Mab Reports Third Quarter 2024 Results - Yahoo Finance
2 weeks from now
1 day ago · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …
yahoo.com
OFF
I-Mab Reports Third Quarter 2024 Results - BioSpace
2 weeks from now
18 hours ago · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …
biospace.com
OFF
I-Mab Reports Third Quarter 2024 Results | Citybiz
2 weeks from now
1 day ago · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …
citybiz.co
OFF
I Mab : Reports Third Quarter 2024 Results Form 6 K
2 weeks from now
1 day ago · Estimated cash runway into 2027, based on $184.4 million in cash and cash equivalents, and short-term investments as of September 30, 2024. ROCKVILLE, MD, …
marketscreener.com
OFF
I-Mab Reports Third Quarter 2024 Results - PR Newswire
2 weeks from now
1 day ago · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …
prnewswire.com
OFF
I-Mab Reports Third Quarter 2024 Results | EPICOS
2 weeks from now
1 day ago · Third Quarter 2024 Financial Results. Cash Position. As of September 30, 2024, the Company had cash and cash equivalents, and short-term investments of $184.4 million, …
epicos.com
OFF
IDenta Corp Reports Third Quarter 2024 Results With 100
2 weeks from now
1 day ago · Net profit for the third quarter of 2024 was $102,344 compared to net profit of ($22,837) in the third quarter of 2023. Cash and cash equivalents increased to $469,615 for …
nasdaq.com
OFF
ALT5 Sigma Reports Fiscal Financial Results For Third Quarter 2024 …
2 weeks from now
2 days ago · Nov 12, 2024 4:50pm EST. Record quarter for ALT5 with Q3 revenue of $4.94 million. New customer onboarding strong in Q3 and continuing into Q4. Launching additional …
nasdaq.com
OFF
ITeos Reports Third Quarter 2024 Financial Results And
2 weeks from now
3 days ago · Third Quarter 2024 Financial Results. Cash and Investment Position: The Company’s cash, cash equivalents, and investments position was $648.9 million as of …
globenewswire.com
OFF
I-Mab Reports Third Quarter 2024 Results
2 weeks from now
1 day ago · Rhea-AI Summary. I-Mab (NASDAQ: IMAB) reported Q3 2024 financial results and pipeline updates. The company ended Q3 with $184.4 million in cash and equivalents, …
stocktitan.net
OFF
Gambling.com Group Reports Third Quarter 2024 Results
2 weeks from now
1 day ago · Third Quarter 2024 and Recent Business Highlights Delivered more than 116,000 new depositing customers (“NDCs”) Repurchased 1,316,975 shares at an average price of $9.35 …
businesswire.com
OFF
Ascendis Pharma Reports Third Quarter 2024 Financial Results
2 weeks from now
21 hours ago · The change was primarily tied the impact of currency fluctuations. For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share …
globenewswire.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension